TLSI•benzinga•
TriSalus Life Sciences confirming FY 2025 guidance of at least 50% revenue growth.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 15, 2025 by benzinga